Lumanity’s Bart Lombardi, Senior Vice President of Strategy Consulting, has been honored with the Corporate Leadership Award by the SDHB PheoPara Coalition.
The SDHB PheoPara Coalition is dedicated to advancing research and education on Pheochromocytoma and Paraganglioma tumors, which are linked to the SDHB genetic mutation. These tumors present a higher risk of malignancy and currently lack effective chemotherapeutic and radiation therapies. The Coalition’s mission includes educating healthcare professionals and patients, as well as supporting research to develop effective treatment options for this rare and challenging condition. Lumanity extends its heartfelt congratulations to Bart Lombardi for this well-deserved recognition and supports the mission of the SDHB PheoPara Coalition.
For more information on the SDHB PheoPara Coalition, please visit http://www.sdhbcoalition.org
